De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre study.

MLA

Oosterhof, P., et al. “De-Simplifying Antiretroviral Therapy from a Single-Tablet to a Two-Tablet Regimen: Acceptance, Patient-Reported Outcomes, and Cost Savings in a Multicentre Study.” HIV Medicine, vol. 25, no. 9, Sept. 2024, pp. 1019–29. EBSCOhost, https://doi.org/10.1111/hiv.13655.

APA

Oosterhof, P., de Zoete, B. G. J. A., Vanhommerig, J. W., Langebeek, N., Gisolf, E. H., van Hulzen, A. G. W., Lammers, A. J. J., Weijsenfeld, A. M., van der Valk, M., Grintjes, K., van Crevel, R., van Luin, M., Brinkman, K., & Burger, D. M. (2024). De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre study. HIV Medicine, 25(9), 1019–1029. https://doi.org/10.1111/hiv.13655

Chicago

Oosterhof, P, B G J A de Zoete, J W Vanhommerig, N Langebeek, E H Gisolf, A G W van Hulzen, A J J Lammers, et al. 2024. “De-Simplifying Antiretroviral Therapy from a Single-Tablet to a Two-Tablet Regimen: Acceptance, Patient-Reported Outcomes, and Cost Savings in a Multicentre Study.” HIV Medicine 25 (9): 1019–29. doi:10.1111/hiv.13655.